KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Ann Coming, page-7

  1. sheaf
    190 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    28/08/15
    15:28
    Post #: 15895146
    Still reading through the report, but on top of p6 it says "The toxicological evaluation of Cantrixil has completed, and a first-in-human trial protocol approved by several Australian Hospital Human Research Ethics committees".
    Same for Anisina.

    So all looks good!
    NRT Price at posting: 15.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS What's causing the cost-of-living crisis, and how to navigate it
right-arrow Created with Sketch.
NEWS Sierra Nevada raises $2M for silver exploration at Blackhawk
right-arrow Created with Sketch.
NEWS Trending Thread: $13.0 million Institutional Placement
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.